MetLife Investment Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.48M | Sell |
25,532
-788
| -3% | -$96.8K | 0.02% | 842 |
|
|
2026
Q1 | $3.1M | Buy |
26,320
+154
| +0.6% | +$21.5K | 0.02% | 831 |
|
|
2025
Q4 | $4.29M | Sell |
26,166
-1,321
| -5% | -$207K | 0.02% | 694 |
|
|
2025
Q3 | $3.67M | Sell |
27,487
-954
| -3% | -$116K | 0.02% | 776 |
|
|
2025
Q2 | $3.54M | Sell |
28,441
-903
| -3% | -$115K | 0.02% | 727 |
|
|
2025
Q1 | $3.73M | Sell |
29,344
-430
| -1% | -$66.2K | 0.02% | 759 |
|
|
2024
Q4 | $4.29M | Buy |
29,774
+2,428
| +9% | +$348K | 0.02% | 650 |
|
|
2024
Q3 | $4.07M | Sell |
27,346
-454
| -2% | -$65.1K | 0.02% | 642 |
|
|
2024
Q2 | $3.5M | Sell |
27,800
-1,810
| -6% | -$284K | 0.02% | 685 |
|
|
2024
Q1 | $5.45M | Sell |
29,610
-750
| -2% | -$143K | 0.04% | 441 |
|
|
2023
Q4 | $5.46M | Sell |
30,360
-451
| -1% | -$70.2K | 0.04% | 411 |
|
|
2023
Q3 | $4.9M | Sell |
30,811
-1,317
| -4% | -$215K | 0.04% | 413 |
|
|
2023
Q2 | $4.54M | Sell |
32,128
-1,184
| -4% | -$190K | 0.03% | 501 |
|
|
2023
Q1 | $5.61M | Sell |
33,312
-842
| -2% | -$150K | 0.04% | 386 |
|
|
2022
Q4 | $5.78M | Sell |
34,154
-699
| -2% | -$127K | 0.04% | 364 |
|
|
2022
Q3 | $6.52M | Sell |
34,853
-364
| -1% | -$76.8K | 0.05% | 296 |
|
|
2022
Q2 | $5.72M | Sell |
35,217
-408
| -1% | -$64.5K | 0.04% | 360 |
|
|
2022
Q1 | $6.7M | Buy |
35,625
+10,707
| +43% | +$2.03M | 0.04% | 365 |
|
|
2021
Q4 | $6.6M | Buy |
24,918
+355
| +1% | +$95.6K | 0.05% | 303 |
|
|
2021
Q3 | $7.1M | Sell |
24,563
-951
| -4% | -$244K | 0.06% | 253 |
|
|
2021
Q2 | $5.09M | Sell |
25,514
-797
| -3% | -$155K | 0.04% | 372 |
|
|
2021
Q1 | $5.12M | Sell |
26,311
-1,231
| -4% | -$252K | 0.05% | 377 |
|
|
2020
Q4 | $5.28M | Sell |
27,542
-414
| -1% | -$75.3K | 0.05% | 338 |
|
|
2020
Q3 | $4.12M | Hold |
27,956
| – | – | 0.05% | 379 |
|
|
2020
Q2 | $3.46M | Sell |
27,956
-20,801
| -43% | -$2.45M | 0.04% | 462 |
|
|
2020
Q1 | $4.71M | Sell |
48,757
-706
| -1% | -$68.2K | 0.06% | 273 |
|
|
2019
Q4 | $4.58M | Sell |
49,463
-81
| -0.2% | -$6.8K | 0.05% | 397 |
|
|
2019
Q3 | $3.8M | Buy |
49,544
+28,368
| +134% | +$2.48M | 0.04% | 470 |
|
|
2019
Q2 | $1.82M | Sell |
21,176
-31,618
| -60% | -$2.16M | 0.02% | 861 |
|
|
2019
Q1 | $3.12M | Buy |
52,794
+35,196
| +200% | +$2.02M | 0.01% | 1043 |
|
|
2018
Q4 | $928K | Hold |
17,598
| – | – | 0.01% | 1046 |
|
|
2018
Q3 | $976K | Hold |
17,598
| – | – | 0.01% | 1133 |
|
|
2018
Q2 | $828K | Hold |
17,598
| – | – | 0.01% | 1111 |
|
|
2018
Q1 | $637K | Hold |
17,598
| – | – | 0.01% | 1231 |
|
|
2017
Q4 | $638K | Buy |
+17,598
| New | +$637K | 0.01% | 1262 |
|
Other funds holding RGEN
UCFA
MC
WA
MetLife Investment Management's RGEN Position: Q2 2026 in Review
MetLife Investment Management reduced its Repligen (RGEN) stake by 3% in Q2 2026, selling an estimated $96.8K and leaving 25,532 shares worth $3.48M. The position accounts for 0.02% of the portfolio, ranked #842.
MetLife Investment Management first reported a position in RGEN in Q4 2017 and has held it in 35 quarters since. The position peaked at $7.1M in Q3 2021. 477 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- MetLife Investment Management held 25,532 shares of Repligen worth $3.48M as of Q2 2026.
- MetLife Investment Management sold 788 Repligen shares in Q2 2026, an estimated $96.8K.
- Repligen made up 0.02% of MetLife Investment Management's portfolio in Q2 2026, its #842 holding.
- MetLife Investment Management first reported a position in Repligen in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Repligen position peaked at $7.1M in Q3 2021.
- 477 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.